Amir Reichman was appointed CEO of BiondVax Pharmaceuticals Ltd.
BioTheryX Inc., a clinical stage company focused on degrading proteins to create life-saving medicines, chose experienced biotechnology leader Robert F. Williamson III as president and CEO and a member of the BioTheryX board of directors.
Florian Dieckmann joined Grünenthal as the new VP and head of global communications.
Duane Barnes is the new head of North America for Swedish Orphan Biovitrum AB (Sobi). He is also part of the company’s executive committee.
Dr. Christina Reimer was appointed chief medical officer at Stockholm-based Alligator Bioscience.
Thierry Fumeaux, M.D., was tapped as chief medical officer of Kinarus, a privately held, development-stage biotechnology company located in Basel, Switzerland.
Immunotherapy company 3T Biosciences picked John Connolly, Ph.D., as interim CEO.
Artios Pharma Ltd. selected Abid Ansari to be chief financial officer.
Eugene Schneider, M.D., was promoted to executive VP and chief clinical development officer of Ionis Pharmaceuticals Inc.
Brian Kotzin, M.D., was appointed as interim chief medical officer, head of development at Nektar Therapeutics.